265989-50-2 (2-羟基阿托伐他汀内酯-d5,2-Hydroxy Atorvastatin Lactone-d5)

[ 2H5 ] - O- 羟基阿托伐他汀内酯标准品;2,4-二溴苯甲酸甲酯;2-羟基阿托伐他汀内酯-d5;

2-Hydroxy Atorvastatin Lactone-d5;5-(4-Fluorophenyl)-N-(2-hydroxyphenyl)-2-(1-Methylethyl)-4-phenyl-1-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1H-pyrrole-3-carboxaMide-d5;5-(4-fluorophenyl)-1-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-N-(2-hydroxyphenyl)-4-(2,3,4,5,6-pentadeuteriophenyl)-2-propan-2-ylpyrrole-3-carboxamide;DTXSID50445260;AKOS030243262;5-(4-FLUOROPHENYL)-1-{2-[(2R,4R)-4-HYDROXY-6-OXOOXAN-2-YL]ETHYL}-N-(2-HYDROXYPHENYL)-2-ISOPROPYL-4-[(2,3,4,5,6-(2)H?)PHENYL]PYRROLE-3-CARBOXAMIDE;J-016493;HY-136346S;265989-50-2;Ortho-hydroxy atorvastatin lactone-d5;CS-0376757;1H-Pyrrole-3-carboxamide, 5-(4-fluorophenyl)-N-(2-hydroxyphenyl)-2-(1-methylethyl)-4-(phenyl-d5)-1-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]- (9CI);

MNECBMZJZFGTIK-AABVQTEKSA-N

1S/C33H33FN2O5/c1-20(2)31-30(33(40)35-26-10-6-7-11-27(26)38)29(21-8-4-3-5-9-21)32(22-12-14-23(34)15-13-22)36(31)17-16-25-18-24(37)19-28(39)41-25/h3-15,20,24-25,37-38H,16-19H2,1-2H3,(H,35,40)/t24-,25-/m1/s1/i3D,4D,5D,8D,9D

FC1C=CC(=CC=1)C1=C(C2C([2H])=C([2H])C([2H])=C([2H])C=2[2H])C(C(NC2C=CC=CC=2O)=O)=C(C(C)C)N1CC[C@@H]1C[C@H](CC(=O)O1)O